Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “anxiety and depression”
Meditation for Depression and Anxiety Symptoms in Dialysis Patients
ClinicalTrials.gov study NCT02686333. IPD Sharing: NO. Countries: 1. Publications: 1.
Examining the Effectiveness of Transdiagnostic, Internet-Delivered Cognitive Behaviour Therapy in New Mothers Experiencing Anxiety and Depression
ClinicalTrials.gov study NCT04012580. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluating a Mobile App for Students Seeking Care for Depression and Anxiety at Harvard University Health Services
ClinicalTrials.gov study NCT03552900. IPD Sharing: NO. Countries: 1. Publications: 20.
Effect of Omega-3 Supplements on Stress, Anxiety, Depression, Memory and Sleep Quality Among Saudis
ClinicalTrials.gov study NCT07157241. IPD Sharing: NO. Countries: 1. Publications: 1.
Breath Control and Mindfulness for Post Concussion Anxiety and Depression: a Feasibility Study
ClinicalTrials.gov study NCT04708522. IPD Sharing: NO. Countries: 1. Publications: 5.
Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression
ClinicalTrials.gov study NCT06384196. IPD Sharing: Not stated. Countries: 1. Publications: 7.
The Impact of Anxiety or Depression on the Sedative Concentration of Propofol
ClinicalTrials.gov study NCT03741361. IPD Sharing: YES. Countries: 1. Publications: 1.
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
ClinicalTrials.gov study NCT05466851. IPD Sharing: NO. Countries: 1. Publications: 6.
Better Sleep in Psychiatric Care - Depression, Anxiety and Trauma, Pilot Study
ClinicalTrials.gov study NCT05379244. IPD Sharing: NO. Countries: 1. Publications: 1.
Assessing the Impact of Isha Kriya Meditation on Anxiety and Depression - a Pilot Study
ClinicalTrials.gov study NCT05065476. IPD Sharing: Not stated. Countries: 1. Publications: 8.
The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms
ClinicalTrials.gov study NCT06701578. IPD Sharing: NO. Countries: 1. Publications: 11.
Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)
ClinicalTrials.gov study NCT03330938. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Negative-Positive Valence Domains in Anxiety and Depression
ClinicalTrials.gov study NCT03310398. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression
ClinicalTrials.gov study NCT02035878. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Exercise to Prevent Depression and Anxiety in Older Hispanics
ClinicalTrials.gov study NCT02371954. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Depression, anxiety and stress in chronic otitis media
Open the record for dataset details and reuse information.
Data from: Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany
Open the record for dataset details and reuse information.
Data from: Anxiety and depressive symptoms are associated with poor sleep health during a period of COVID-19 induced nation-wide lockdown: a cross-sectional analysis of adults in the Middle East
<p><strong>Background</strong>: Jordan, a Middle Eastern country, declared a state of national emergency due to the novel coronavirus (COVID-19) and a strict nation-wide lockdown on March 17, 2020, banning all travel and movement around the country, potentially impacting mental health. This study sought to investigate the association between mental health (e.g., anxiety and depressive symptoms) and sleep health among a sample of Jordanians living through a state of COVID-19 induced nation-wide lockdown.</p> <p><strong>Methods</strong>: Using Facebook, participants (N=1,240) in Jordan in March 2020 were recruited and direct to a web-based survey measuring anxiety (items from GAD-7 instrument), depressive symptoms (items from DES-10), sleep health (items from the PSQI), and sociodemographic. A modified Poisson regression model with robust error variance. Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) were estimated to examine how anxiety and depressive symptoms may affect different dimensions of sleep health: 1) poor sleep quality, 2) short sleep duration, 3) encountering sleep problems.</p> <p><strong>Results</strong>: The majority of participants reported having experienced mild (33.8%), moderate (12.9%), or severe (6.3%) levels of anxiety during lockdown, and nearly half of respondents reported depressive symptoms during lockdown. Similarly, over 60 percent of participants reported having experienced at least one sleep problem in the last week, and nearly half reported having had short sleep duration. Importantly, Anxiety was associated with poor sleep health outcomes. For example, corresponding to the dose-response relationship between anxiety and sleep health outcomes, those reporting severe anxiety were the most likely to experience poor sleep quality (aPR =8.95; 95% CI =6.12–13.08), short sleep duration (aPR =2.23; 95% CI = 1.91–2.61), and at least one problem sleep problem (aPR = 1.73; 95% CI = 1.54–1.95). Moreover, depressive symptoms were also associated with poor sleep health outcomes. As compared to scoring in the first quartile, scoring fourth quartile was associated with poor sleep quality (aPR = 11.82; 95% CI = 6.64 – 21.04), short sleep duration (aPR = 1.87; 95% CI = 1.58–2.22), and experiencing at least one sleep problem (aPR = 1.90; 95% CI = 1.66 – 2.18).</p> <p><strong>Conclusions</strong>: Increased levels of anxiety and depressive symptoms can negatively influence sleep health among a sample of Jordanian adults living in a state of COVID-19<br> induced nation-wide lockdown.</p>
Prevalence of depression, anxiety and stress and their risk and protective factors among secondary students in Rwanda during the first wave of COVID-19 pandemic.
Open the record for dataset details and reuse information.
Adherence to the Mediterranean diet and risk of anxiety and depression in people with obesity: a cross-sectional analysis
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.